124 related articles for article (PubMed ID: 30470726)
1. A proteasomal partner goes missing in Angelman syndrome.
Huibregtse JM
J Biol Chem; 2018 Nov; 293(47):18400-18401. PubMed ID: 30470726
[TBL] [Abstract][Full Text] [Related]
2. Angelman syndrome-associated point mutations in the Zn
Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
[TBL] [Abstract][Full Text] [Related]
3. Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome.
Tomaić V; Banks L
Cell Death Dis; 2015 Jan; 6(1):e1625. PubMed ID: 25633294
[TBL] [Abstract][Full Text] [Related]
4. The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.
Yi JJ; Paranjape SR; Walker MP; Choudhury R; Wolter JM; Fragola G; Emanuele MJ; Major MB; Zylka MJ
J Biol Chem; 2017 Jul; 292(30):12503-12515. PubMed ID: 28559284
[TBL] [Abstract][Full Text] [Related]
5. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein.
Cooper EM; Hudson AW; Amos J; Wagstaff J; Howley PM
J Biol Chem; 2004 Sep; 279(39):41208-17. PubMed ID: 15263005
[TBL] [Abstract][Full Text] [Related]
6. Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants.
Offensperger F; Müller F; Jansen J; Hammler D; Götz KH; Marx A; Sirois CL; Chamberlain SJ; Stengel F; Scheffner M
Cell Chem Biol; 2020 Dec; 27(12):1510-1520.e6. PubMed ID: 32966807
[TBL] [Abstract][Full Text] [Related]
7. Human disorders of ubiquitination and proteasomal degradation.
Jiang YH; Beaudet AL
Curr Opin Pediatr; 2004 Aug; 16(4):419-26. PubMed ID: 15273504
[TBL] [Abstract][Full Text] [Related]
8. Angelman syndrome scientific symposium on the structure and function of UBE3A/E6AP.
Williams C
J Child Neurol; 2009 Jul; 24(7):904-8. PubMed ID: 19617463
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling.
Furusawa K; Ishii K; Tsuji M; Tokumitsu N; Hasegawa E; Emoto K
Science; 2023 Sep; 381(6663):1197-1205. PubMed ID: 37708280
[TBL] [Abstract][Full Text] [Related]
10. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
11. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders.
LaSalle JM; Reiter LT; Chamberlain SJ
Epigenomics; 2015 Oct; 7(7):1213-28. PubMed ID: 26585570
[TBL] [Abstract][Full Text] [Related]
13. Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.
Pandya NJ; Wang C; Costa V; Lopatta P; Meier S; Zampeta FI; Punt AM; Mientjes E; Grossen P; Distler T; Tzouros M; Martí Y; Banfai B; Patsch C; Rasmussen S; Hoener M; Berrera M; Kremer T; Dunkley T; Ebeling M; Distel B; Elgersma Y; Jagasia R
Cell Rep Med; 2021 Aug; 2(8):100360. PubMed ID: 34467244
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
[TBL] [Abstract][Full Text] [Related]
15. The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches.
Lu Y; Wang F; Li Y; Ferris J; Lee JA; Gao FB
Hum Mol Genet; 2009 Feb; 18(3):454-62. PubMed ID: 18996915
[TBL] [Abstract][Full Text] [Related]
16. Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome.
Avagliano Trezza R; Sonzogni M; Bossuyt SNV; Zampeta FI; Punt AM; van den Berg M; Rotaru DC; Koene LMC; Munshi ST; Stedehouder J; Kros JM; Williams M; Heussler H; de Vrij FMS; Mientjes EJ; van Woerden GM; Kushner SA; Distel B; Elgersma Y
Nat Neurosci; 2019 Aug; 22(8):1235-1247. PubMed ID: 31235931
[TBL] [Abstract][Full Text] [Related]
17. Angelman Syndrome Due to UBE3A Gene Mutation.
Goswami JN; Sahu JK; Singhi P
Indian J Pediatr; 2018 May; 85(5):390-391. PubMed ID: 29250725
[TBL] [Abstract][Full Text] [Related]
18. Mutation Update for UBE3A variants in Angelman syndrome.
Sadikovic B; Fernandes P; Zhang VW; Ward PA; Miloslavskaya I; Rhead W; Rosenbaum R; Gin R; Roa B; Fang P
Hum Mutat; 2014 Dec; 35(12):1407-17. PubMed ID: 25212744
[TBL] [Abstract][Full Text] [Related]
19. Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes.
Martínez-Noël G; Galligan JT; Sowa ME; Arndt V; Overton TM; Harper JW; Howley PM
Mol Cell Biol; 2012 Aug; 32(15):3095-106. PubMed ID: 22645313
[TBL] [Abstract][Full Text] [Related]
20. Angelman syndrome-derived neurons display late onset of paternal UBE3A silencing.
Stanurova J; Neureiter A; Hiber M; de Oliveira Kessler H; Stolp K; Goetzke R; Klein D; Bankfalvi A; Klump H; Steenpass L
Sci Rep; 2016 Aug; 6():30792. PubMed ID: 27484051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
